Coronary artery disease is one of the leading causes of morbidity and mortality, and its
prevalence increases with age. The growing number of older patients and their differential …

Percutaneous coronary intervention (PCI) of severely calcified lesions is known to result in
lower procedural success rates, higher complication rates, and worse long‐term clinical …

Background Heart failure hospitalizations are a major financial cost to healthcare systems.
This study aimed to evaluate the costs associated with inpatient hospitalization. Methods …

Background Little is known about frailty amongst patients hospitalized with heart failure (HF)
on a national level. Methods We conducted a retrospective cohort study of patients admitted …

There is growing awareness that frailty may be an important marker of adverse outcomes in
PCI but there is no literature from national cohorts. This study examines a national cohort of …

This study examines a national cohort of patients with a diagnosis of acute coronary
syndrome (ACS) for the prevalence of frailty, temporal changes over time, and its association …

Although rotational atherectomy (RA) and intravascular lithotripsy (IVL) have been proved to
be effective for calcified de novo coronary lesions, their use in patients with in-stent …

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor in patients
undergoing percutaneous coronary intervention (PCI) reduces the risk of ischemic events …

Background Readmissions after PCI are a burden to patients and health services that are
not well understood. Methods A systematic review was performed to identify studies of …

Aims Heart failure (HF) outcomes continue to improve with widespread use of new
therapies. Concurrently, cancer survival has dramatically improved. Yet whether cancer …